Cargando…
Regression of cardiac amyloid load documented by cardiovascular magnetic resonance in a patient with hereditary amyloidosis
Autores principales: | Florian, Anca, Bietenbeck, Michael, Chatzantonis, Grigorios, Hüsing-Kabar, Anna, Schmidt, Hartmut, Yilmaz, Ali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7308258/ https://www.ncbi.nlm.nih.gov/pubmed/32048001 http://dx.doi.org/10.1007/s00392-020-01611-2 |
Ejemplares similares
-
Genome silencer therapy leading to ‘regression’ of cardiac amyloid load on cardiovascular magnetic resonance: a case report
por: Florian, Anca, et al.
Publicado: (2021) -
Diagnostic value of the novel CMR parameter “myocardial transit-time” (MyoTT) for the assessment of microvascular changes in cardiac amyloidosis and hypertrophic cardiomyopathy
por: Chatzantonis, Grigorios, et al.
Publicado: (2020) -
Clinical experience regarding safety and diagnostic value of cardiovascular magnetic resonance in patients with a subcutaneous implanted cardioverter/defibrillator (S-ICD) at 1.5 T
por: Holtstiege, Viktoria, et al.
Publicado: (2020) -
CMR-based T1-mapping offers superior diagnostic value compared to longitudinal strain-based assessment of relative apical sparing in cardiac amyloidosis
por: Korthals, Dennis, et al.
Publicado: (2021) -
Diagnostic value of cardiovascular magnetic resonance in comparison to endomyocardial biopsy in cardiac amyloidosis: a multi-centre study
por: Chatzantonis, Grigorios, et al.
Publicado: (2020)